Medifast, Inc.MEDNYSE
Loading
Cost of Revenue Over TimeContracting
Percentile Rank50
3Y CAGR-37.7%
5Y CAGR-14.1%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
-37.7%/yr
vs +39.5%/yr prior
5Y CAGR
-14.1%/yr
Recent deceleration
Acceleration
-77.2pp
Decelerating
Percentile
P50
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
3 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $110.60M | -29.9% |
| 2024 | $157.84M | -46.7% |
| 2023 | $296.20M | -35.3% |
| 2022 | $458.16M | +15.0% |
| 2021 | $398.49M | +68.1% |
| 2020 | $237.03M | +34.1% |
| 2019 | $176.81M | +46.0% |
| 2018 | $121.10M | +64.2% |
| 2017 | $73.75M | +7.1% |
| 2016 | $68.87M | - |